Weight-Loss Medicines and Sleep Apnea: What Tirzepatide Means for You

Tirzepatide is a weight-loss medicine. In two large trials, it helped adults with obesity and moderate-to-severe sleep apnea. Over one year, it lowered breathing pauses during sleep by about 20 to 24 more events per hour than a placebo (a dummy pill or shot)¹. People taking it also lost weight and reported better sleep and daily functioning². These medicines are not right for everyone, so the best next step is a talk with your doctor.

What is obstructive sleep apnea, and how is it measured?

Obstructive sleep apnea (OSA) happens when the throat narrows or closes again and again during sleep. Each time, breathing slows or stops for a few seconds and oxygen can drop. The brain briefly wakes up to restart breathing. Most people do not remember these wake-ups, but they may feel tired, snore loudly or wake with headaches.

Doctors measure sleep apnea with the apnea-hypopnea index (AHI). The AHI is the number of times per hour that breathing stops or becomes very shallow during sleep¹. An AHI of 15 to 29 is usually called moderate. An AHI of 30 or more is called severe³.

Why does weight matter for sleep apnea?

Extra body weight is a major risk factor for sleep apnea. Researchers describe excess body fat as one of the underlying causes of OSA¹. Studies have shown that losing weight can make sleep apnea less severe³. In one trial, people who lost more weight saw more improvement in their sleep apnea measures³.

What did the tirzepatide trials find?

Tirzepatide is a prescription medicine that helps people lose weight. The SURMOUNT-OSA program tested it in two one-year trials. The people in them were adults with obesity and moderate-to-severe OSA¹. One trial included people who were not using a breathing machine. The other included people already using positive airway pressure (PAP) therapy, such as CPAP¹.

At the start, people had an average AHI of about 50 events per hour, which is severe. After 52 weeks¹:

• First trial — AHI fell by about 25 events per hour with tirzepatide. It fell by about 5 with placebo.
• Second trial — AHI fell by about 29 events per hour with tirzepatide. It fell by about 5 or 6 with placebo.
• Other gains — Tirzepatide also lowered body weight and systolic blood pressure (the top number). It lowered a marker of inflammation, too. It also lowered "hypoxic burden," a measure of how much oxygen levels drop during sleep.

Did people feel better on tirzepatide?

A follow-up report looked at how people felt. Compared with placebo, people taking tirzepatide reported:²

• Better sleep — Less sleep-related impairment and fewer sleep disturbances.
• Better days — Better daily functioning and better overall quality of life.
• Less sleepiness — In the first trial, they also reported less daytime sleepiness².

How do other GLP-1 medicines compare?

Tirzepatide is related to a group of medicines called GLP-1 receptor agonists. These are used to treat obesity and diabetes⁴. An earlier trial tested liraglutide 3.0 mg in adults with obesity and moderate or severe OSA. These people could not or would not use CPAP³. After 32 weeks, AHI fell by about 12 events per hour with liraglutide and 6 with placebo. People on liraglutide lost about 5.7% of their body weight³.

A 2025 review combined six studies with more than 1,000 people. Overall, GLP-1 medicines lowered AHI by about 9.5 events per hour. They also led to weight loss and lower blood pressure⁴. Tirzepatide lowered AHI much more than liraglutide did⁴. So liraglutide helped too, but by a smaller amount³⁴. The reviewers noted that more high-quality trials are still needed to learn which people benefit most⁴.

What are the side effects?

In the tirzepatide trials, the most common side effects affected the stomach and gut. Most were mild to moderate¹. Liraglutide was generally well tolerated in its trial³.

Every medicine has risks as well as benefits, and your own health history matters. Starting, changing or stopping any medicine is a decision to make with your doctor. Only your doctor can help you decide whether one of these medicines fits your situation.

Can a weight-loss medicine replace CPAP?

CPAP (continuous positive airway pressure) is a bedside machine. It gently blows air through a mask to keep the airway open during sleep. In the trials, many people still had some sleep apnea after a year of tirzepatide, even though it improved a lot¹. The review found that GLP-1 medicines worked whether or not people were also using CPAP⁴. This suggests the two can be used together.

Sleep apnea can change as weight changes. So a repeat sleep test may help show where things stand. Any change to CPAP use should be planned with your sleep doctor, not made on your own.

At Universal Sleep Solutions, we offer in-lab and home sleep testing, CPAP and BiPAP setup and follow-up, Inspire evaluation, and oral appliance referral. That means your sleep apnea care can keep up with your progress, whatever path you and your doctors choose.

When should you get checked for sleep apnea?

Consider a sleep evaluation if you have obesity and any of these signs:

• Night signs — Loud snoring, or someone has seen you stop breathing or gasp in your sleep.
• Day signs — Daytime sleepiness, morning headaches or trouble focusing.
• Blood pressure — High blood pressure that is hard to control.
• Starting a medicine — You are thinking about a weight-loss medicine and want to know how your sleep apnea may change.
• Big weight loss — You have lost a lot of weight and wonder whether your CPAP settings still fit.

A sleep study is the only way to know how severe your sleep apnea is today. Talk with your doctor or contact Universal Sleep Solutions to schedule an evaluation.